Intra-Cellular Therapies (ITCI) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist

127.820
-0.240-0.19%

Close Feb 14 16:00 ET

128.130
+0.310+0.24%

Post 20:01 ET

13.58BMarket Cap-146.92P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

It's Time for Investors to Rotate, With Opportunities Down the Market Cap – Piper Sandler
Seeking AlphaFeb 12 11:09 ET
Morgan Stanley Maintains Intra-Cellular Therapies(ITCI.US) With Hold Rating, Maintains Target Price $132
Moomoo NewsFeb 6 08:31 ET · Ratings
Morgan Stanley Remains a Hold on Intra-Cellular Therapies (ITCI)
TipRanksFeb 6 08:16 ET · Ratings
UBS Maintains Intra-Cellular Therapies(ITCI.US) With Hold Rating, Raises Target Price to $132
Moomoo NewsFeb 5 19:31 ET · Ratings
UBS Adjusts Price Target on Intra-Cellular Therapies to $132 From $87, Maintains Neutral Rating
MT NewswiresFeb 5 08:22 ET · Ratings
CCORF Maintains Intra-Cellular Therapies(ITCI.US) With Hold Rating, Maintains Target Price $132
Moomoo NewsJan 31 09:31 ET · Ratings

Comments

Meta Moo

Jan 17 12:53

Columns Johnson & Johnson Sees Possible Bullish Chart Ahead of Earnings

$Johnson & Johnson (JNJ.US)$ will report Q4 numbers next Wednesday (Jan. 22) at a time when the medical company’s stock has been under the weather, falling back some 14% since early September even as the S&P 500 gained about 7%. What does JNJ's technical and fundamental analysis say could happen from here?
Let's look:
Johnson & Johnson's Fundamental Analysis
The Street is looking for JNJ to report $2.04 in adjusted Q4 earnings per sha...

Kevin Travers

Jan 13 15:07

Columns Wall Street Today: Market Turns Around, Let's See if it Lasts

Overall, the market pulled a fast one on traders on Monday. The S&P 500 started down but built into a climb by the end of the day.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.16%, the $Dow Jones Industrial Average (.DJI.US)$ was climbing 0.86%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 0.38%.
MACRO
In macroeconomic news this week, watch for Fed speakers, CPI inflation data on Wednesday, and Retail sale data on Thursday.
SECTORS
This week is the s...

Weekly Buzz

Kevin Travers

Jan 13 09:52

Columns Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season

Happy Monday, January 13th. The market began the week falling, but you'll never guess why: here's the Live Stock news.
$Moderna (MRNA.US)$ is falling 21% on Monday, the lowest percentage decliner on the S&P 500 after the firm updated its 2025 guidance, slashing its sales and revenue guidance by $1B, from a range of $2.5-$3.5B it gave in Sept.
$Micron Technology (MU.US)$ was one of the largest percentage ...

Live Stock Financial Podcast. What are you watching on the market?

103418136

Jan 13 08:35

$Intra-Cellular Therapies (ITCI.US)$ am i buy too high at $125?

Movers and Shakers

Jan 13 07:45

Columns Today's Pre-Market Movers and Top Ratings | ANF, LULU, ITCI and More

Morning Movers
Gapping up
$Lululemon Athletica (LULU.US)$ shares climbed 3.9% after the company raised its current-quarter targets, driven by strong holiday-season demand for its apparel.
$Enfusion (ENFN.US)$ shares surged 12% after Clearwater Analytics (NYSE:CWAN), which rose 1.7%, announced a $1.5 billion cash-and-stock acquisition of the investment management platform.
$Intra-Cellular Therapies (ITCI.US)$ shares skyrocketed 35% ...

ITCI Intra-Cellular Therapies

Trade Overview

Capital Trend

News

Comments

Trending Stocks